drugset / Trial / NCT01431508
A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is being conducted to evaluate the safety and antihypertensive efficacy of MK-0954A (Losartan 50 mg / Hydrochlorothiazide (HCTZ) 12.5 mg) in participants with mild to moderate essential hypertension.
Timeline
- Start
- 2007-08-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Subject | Losartan | Other / unclassified | 50 mg | — |